32 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.
(t) Title
S-3ASR
EX-1.2
4wqlerzzbs814r3twtq3
4 Aug 21
Automatic shelf registration
4:11pm
DEF 14A
2q1a50th8dm
25 Mar 21
Definitive proxy
6:03am
424B4
3bi0g kykbqjupf8al0
5 Mar 21
Prospectus supplement with pricing info
4:07pm
DRS
4u55m25hbk
22 Feb 21
Draft registration statement
12:00am
10-K
ptey2jz588ad6 rw
16 Feb 21
Annual report
4:11pm